HomeEDIT • NASDAQ
add
Editas Medicine Inc
Nakaraang pagsara
$2.54
Sakop ng araw
$2.45 - $2.64
Sakop ng taon
$0.91 - $4.54
Market cap
241.74M USD
Average na Volume
1.83M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 24.74M | -19.16% |
Gastos sa pagpapatakbo | 11.35M | -30.58% |
Net na kita | -5.62M | 87.62% |
Net profit margin | -22.72 | 84.68% |
Kita sa bawat share | -0.06 | 89.09% |
EBITDA | -13.21M | 57.64% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 146.64M | -45.67% |
Kabuuang asset | 186.53M | -45.39% |
Kabuuang sagutin | 159.25M | -23.19% |
Kabuuang equity | 27.29M | — |
Natitirang share | 97.87M | — |
Presyo para makapag-book | 9.07 | — |
Return on assets | -18.05% | — |
Return on capital | -89.28% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -5.62M | 87.62% |
Cash mula sa mga operasyon | -36.39M | 28.32% |
Cash mula sa pag-invest | 58.00K | -99.81% |
Cash mula sa financing | 17.33M | -68.79% |
Net change in cash | -19.00M | -153.22% |
Malayang cash flow | -27.36M | -19.33% |
Tungkol
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Itinatag
Nob 2013
Website
Mga Empleyado
87
